Texas Cancer Agency Stops Grants

The Cancer Prevention and Research Institute of Texas has agreed to stop awarding new grants until it addresses concerns about the integrity of is review process.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, KUEBIAt the written request of Texas governor Rick Perry (R), the state’s embattled $3 billion dollar cancer research funding agency this week announced a moratorium on new grants, reported ScienceInsider. The agency will award no more grants until it properly addresses continued concerns about the legitimacy of its review procedures.

The Cancer Prevention and Research Institute of Texas (CPRIT) has been in trouble since May 2012, when its chief scientific officer, the Nobel Prize-winning biochemist Alfred Gilman, announced he would quit over grave concerns about the integrity of the agency’s peer-review procedure. Gilman stepped down in October, and was quickly followed by the chair of the review council and scores of peer reviewers.

Two more top officials, including the agency’s executive director, Bill Gimson, have resigned in the past few weeks amid allegations about possible criminal activity involving a round of grants awarded to companies owned by Dallas businessman David Shanahan, a major campaign contributor to Texas Governor Perry and Lieutenant Governor David Dewhurst.

Following the commencement of a civil investigation, CPRIT this week received ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery